Health Care

Sloan Kettering’s Crisis

A Reckoning Over Industry Ties

Memorial Sloan Kettering Cancer Center in New York is re-examining conflicts of interest after articles by ProPublica and The New York Times highlighted the relationships between its staff and health care companies.

Impact of Our Reporting

Sloan Kettering’s Crisis

Top Official at Memorial Sloan Kettering Resigns After Failing to Disclose Industry Ties

Dr. José Baselga, the hospital’s chief medical officer, stepped down days after a report by ProPublica and the New York Times that he failed to disclose millions of dollars in payments from the health care and drug industry in research articles.

by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times, Sept. 13, 2018, 8:45 p.m. EDT

Memorial Sloan Kettering Gave Top Doctor $1.5 Million After He Was Forced to Resign Over Conflicts of Interest

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica,

Dec. 22, 2020, 2:04 p.m. EST

Memorial Sloan Kettering Leaders Violated Conflict-of-Interest Rules, Report Finds

by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times,

April 4, 2019, 3:41 p.m. EDT

Memorial Sloan Kettering Curbs Executives’ Ties to Industry After Conflict-of-Interest Scandals

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica,

Jan. 11, 2019, 7:05 p.m. EST

Top Cancer Doctor, Forced Out Over Ties to Drug Makers, Joins Their Ranks

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica,

Jan. 7, 2019, 6:17 p.m. EST

Memorial Sloan Kettering’s Season of Turmoil

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica,

Dec. 31, 2018, 10:30 a.m. EST

Top Cancer Doctor Resigns as Editor of Medical Journal

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica,

Dec. 19, 2018, 3:30 p.m. EST

Sloan Kettering Cancer Researchers Correct the Record by Revealing Company Ties

by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times,

Oct. 12, 2018, 3:15 p.m. EDT

Memorial Sloan Kettering’s Chief Executive Resigns From Merck’s Board of Directors

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica,

Oct. 2, 2018, 4 p.m. EDT

Cancer Center’s Board Chairman Faults Top Doctor, Saying He “Crossed Lines”

by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times,

Oct. 1, 2018, 7:30 p.m. EDT

Facing Crisis, Sloan Kettering Tells Exec to Hand Over Profits From Biotech

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica,

Sept. 29, 2018, 12:15 p.m. EDT

Cancer Center Switches Focus on Fundraising as Problems Mount

by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times,

Sept. 25, 2018, 8 p.m. EDT

Sloan Kettering’s Cozy Deal With Start-Up Ignites a New Uproar

by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times,

Sept. 20, 2018, 4:10 p.m. EDT

Sloan Kettering Cancer Center Orders Staff to “Do a Better Job” of Disclosing Industry Ties

by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica,

Sept. 9, 2018, 4 p.m. EDT

Top Cancer Researcher Fails to Disclose Corporate Financial Ties in Major Research Journals

by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times,

Sept. 8, 2018, 1 p.m. EDT